Published in JACC Cardiovasc Interv on February 01, 2012
Some Ethical Legal Issues in Heart Disease Surgery. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2014) 0.75
Live case demonstration of interventional cardiology procedures: is it really safe? JACC Cardiovasc Interv (2012) 0.75
Live case demonstration of interventional cardiology procedures: a regulatory perspective. JACC Cardiovasc Interv (2012) 0.75
Live case demonstrations in cardiology. Are patients exposed to risk? Eur Heart J (2013) 0.75
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation (2011) 6.36
Modelling the long QT syndrome with induced pluripotent stem cells. Nature (2011) 5.68
A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol (2004) 5.67
Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol (2007) 4.05
Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol (2011) 3.37
Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria. Circulation (2004) 3.35
Arrhythmogenic right ventricular dysplasia: a United States experience. Circulation (2005) 2.94
Impact of collateral flow to the occluded infarct-related artery on clinical outcomes in patients with recent myocardial infarction: a report from the randomized occluded artery trial. Circulation (2010) 2.88
Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet (2009) 2.82
A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med (2011) 2.81
Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation (2005) 2.80
A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol (2010) 2.62
Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Cardiovasc Electrophysiol (2004) 2.59
Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. J Am Coll Cardiol (2011) 2.49
Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial. Circulation (2009) 2.47
Changes in haemoglobin levels during hospital course and long-term outcome after acute myocardial infarction. Eur Heart J (2007) 2.46
Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol (2005) 2.42
Integrated single-photon emission computed tomography and computed tomography coronary angiography for the assessment of hemodynamically significant coronary artery lesions. J Am Coll Cardiol (2007) 2.42
Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation (2006) 2.36
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J (2011) 2.11
Impact of red blood cell transfusion on clinical outcomes in patients with acute myocardial infarction. Am J Cardiol (2008) 2.05
Human embryonic and induced pluripotent stem cell-derived cardiomyocytes exhibit beat rate variability and power-law behavior. Circulation (2012) 2.02
Real-time MRI-guided right heart catheterization in adults using passive catheters. Eur Heart J (2012) 2.00
Successful cervical MR scan in a patient several hours after pacemaker implantation. Pacing Clin Electrophysiol (2009) 2.00
Gaps in the ablation line as a potential cause of recovery from electrical isolation and their visualization using MRI. Circ Arrhythm Electrophysiol (2011) 1.95
Genotyping of the common haptoglobin Hp 1/2 polymorphism based on PCR. Clin Chem (2002) 1.90
Characterization of radiofrequency ablation lesions with gadolinium-enhanced cardiovascular magnetic resonance imaging. J Am Coll Cardiol (2006) 1.89
A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial. J Am Coll Cardiol (2010) 1.80
Calcium handling in human embryonic stem cell-derived cardiomyocytes. Stem Cells (2008) 1.75
Left Cardiac Sympathetic Denervation in Patients with CASQ2-Associated Catecholaminergic Polymorphic Ventricular Tachycardia. Isr Med Assoc J (2015) 1.70
Outcomes of patients with coronary artery perforation complicating percutaneous coronary intervention and correlations with the type of adjunctive antithrombotic therapy: pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials. J Interv Cardiol (2009) 1.64
Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study. J Am Coll Cardiol (2003) 1.62
Novel solid-state-detector dedicated cardiac camera for fast myocardial perfusion imaging: multicenter comparison with standard dual detector cameras. J Nucl Cardiol (2009) 1.60
Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm (2013) 1.57
Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies. Circulation (2008) 1.57
C-Reactive protein is inversely related to physical fitness in middle-aged subjects. Atherosclerosis (2004) 1.55
Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation. J Cell Mol Med (2012) 1.55
Percutaneous coronary interventions in diabetic patients: is complete revascularization important? J Invasive Cardiol (2004) 1.53
Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction. Diabetes (2005) 1.53
Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol (2005) 1.52
Stereotactic magnetic resonance guidance for anatomically targeted ablations of the fossa ovalis and the left atrium. J Interv Card Electrophysiol (2004) 1.48
Hyperglycemia during acute myocardial infarction in patients who are treated by primary percutaneous coronary intervention: impact on long-term prognosis. Int J Cardiol (2007) 1.47
Impact of bivalirudin therapy in high-risk patients with acute myocardial infarction: 1-year results from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial. JACC Cardiovasc Interv (2010) 1.46
Inverse association between pulmonary function and C-reactive protein in apparently healthy subjects. Am J Respir Crit Care Med (2006) 1.46
Increased level of cardiorespiratory fitness blunts the inflammatory response in metabolic syndrome. Int J Cardiol (2005) 1.45
Coronary reperfusion and clinical outcomes after thrombus aspiration during primary percutaneous coronary intervention: findings from the HORIZONS-AMI trial. Catheter Cardiovasc Interv (2013) 1.44
Should primary percutaneous coronary intervention be the preferred method of reperfusion therapy for patients with renal failure and ST-elevation acute myocardial infarction? Am J Cardiol (2006) 1.44
Aortic access from the vena cava for large caliber transcatheter cardiovascular interventions: pre-clinical validation. J Am Coll Cardiol (2013) 1.44
Internal defibrillation with minimal skeletal muscle activation: a new paradigm toward painless defibrillation. Heart Rhythm (2005) 1.43
Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein. J Am Coll Cardiol (2006) 1.43
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, eptifibatide and abciximab: outcomes, complications and thrombocytopenia during percutaneous coronary intervention. J Invasive Cardiol (2003) 1.42
Glycoprotein IIb/IIIa inhibitors during rescue percutaneous coronary intervention in acute myocardial infarction. J Invasive Cardiol (2006) 1.42
Staged versus one-step approach for multivessel percutaneous coronary interventions. Am Heart J (2002) 1.40
Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial. Catheter Cardiovasc Interv (2014) 1.40
Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation (2005) 1.40
An unusual cause for ventricular fibrillation following cardiac surgery. Isr Med Assoc J (2013) 1.40
Predictors of high-risk angiographic findings in patients with non-ST-segment elevation acute coronary syndrome. Catheter Cardiovasc Interv (2013) 1.39
Contrast enhanced multi-detector computed tomography coronary angiography versus conventional invasive quantitative coronary angiography in acute coronary syndrome patients-correlation and bias. Acute Card Care (2006) 1.39
Analysis of left and right ventricular Doppler tissue imaging in patients undergoing percutaneous closure of patent foramen ovale. J Invasive Cardiol (2007) 1.39
Comparison of safety and efficacy between first and second generation of angio-seal closure devices in interventional patients. J Invasive Cardiol (2004) 1.39
Repeat in-stent restenosis of drug-eluting stents in a bifurcation treated successfully with kissing drug eluting balloons. Cardiovasc Revasc Med (2012) 1.38
Initial experience with the Amplatzer membranous septal occluder in adults. Acute Card Care (2007) 1.38
The impact of GP IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction patients. J Invasive Cardiol (2005) 1.38
Autosomal recessive dilated cardiomyopathy due to DOLK mutations results from abnormal dystroglycan O-mannosylation. PLoS Genet (2011) 1.36
Hypoxia-inducible factor 1alpha polymorphism and coronary collaterals in patients with ischemic heart disease. Chest (2005) 1.35
16-MDCT coronary angiography versus invasive coronary angiography in acute chest pain syndrome: a blinded prospective study. AJR Am J Roentgenol (2006) 1.34
Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction. Atherosclerosis (2006) 1.30
Hyponatremia and long-term mortality in survivors of acute ST-elevation myocardial infarction. Arch Intern Med (2006) 1.30
Quality of life, depressed mood, and self-esteem in adolescents with heart disease. Psychosom Med (2007) 1.26
Cardiac calcified amorphous tumor in a patient presenting for ventricular tachycardia ablation: intracardiac echocardiogram diagnosis and management. J Interv Card Electrophysiol (2009) 1.24
Is functional improvement after myocardial infarction predicted with myocardial enhancement patterns at multidetector CT? Radiology (2007) 1.23
Stent deployment failure: reasons, implications, and short- and long-term outcomes. Catheter Cardiovasc Interv (2003) 1.21
Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. Eur Heart J (2009) 1.21
Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials. J Am Coll Cardiol (2006) 1.17
Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial. J Am Coll Cardiol (2005) 1.15
Haptoglobin phenotype and coronary artery collaterals in diabetic patients. Atherosclerosis (2002) 1.13